Clinical Trial

Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency.

Name: Study on Supplement of Intravenous Ferric Derisomaltose to Prevent Anemia and Improve the Quality of Life in Obese Patients With Iron Deficiency. — clinical trial record (NCT07236788)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aimed to explore the effects of preoperative intravenous isomaltose iron supplementation versus placebo on postoperative Hb improvement, prevention of postoperative anemia, and improvement in quality of life in patients undergoing bariatric surgery.

Trial Details

NCT Number	NCT07236788
Lead Sponsor	China-Japan Friendship Hospital
Conditions	Obesity, Anemia, Iron Deficiencies, Bariatric Surgery
Enrollment	200 participants
Start Date	2025-03-01
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-03-30 (estimated)
Updated on ClinicalTrials.gov	2025-11-19